Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas

Gynecologic Oncology

Volumn 123, Issue 1, 2011, Pages 5-12

  Karst, Alison M ^a   Levanon, Keren ^a,d   Duraisamy, Sekhar ^a   Liu, Joyce F ^a   Hirsch, Michelle S ^b   Hecht, Jonathan L ^c   Drapkin, Ronny ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Fallopian tube; Ovarian cancer; p27; Pelvic serous carcinoma; Stathmin 1; TP53

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P27; PROTEIN P53; STATHMIN 1; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; CANCER CELL; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CARCINOMA; CELL MIGRATION; CELL POLARITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MICROTUBULE; OVARY CANCER; PELVIC SEROUS CARCINOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UTERINE TUBE; WESTERN BLOTTING;

ADULT; AGED; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYSTADENOCARCINOMA, SEROUS; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; MICROTUBULES; MIDDLE AGED; OVARIAN NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; STATHMIN; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80052576079     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.05.021     Document Type: Article

References (42)

1. R.J. Morgan Jr., R.D. Alvarez, D.K. Armstrong, B. Boston, L.M. Chen, and L. Copeland Ovarian cancer. Clinical practice guidelines in oncology J Natl Compr Canc Netw 6 8 Sep 2008 766 794
2. R.M. Bukowski, R.F. Ozols, and M. Markman The management of recurrent ovarian cancer Semin Oncol 34 2 Suppl 2 2007 Apr S1 S15
3. C.P. Crum, R. Drapkin, D. Kindelberger, F. Medeiros, A. Miron, and Y. Lee Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer Clin Med Res 5 1 2007 Mar 35 44 (Pubitemid 350218778)
4. A.M. Karst, and R. Drapkin Ovarian cancer pathogenesis: a model in evolution J Oncol 2010 2010 932371
5. K. Levanon, C. Crum, and R. Drapkin New insights into the pathogenesis of serous ovarian cancer and its clinical impact J Clin Oncol 26 32 2008 Nov 10 5284 5293
6. Y. Lee, A. Miron, R. Drapkin, M.R. Nucci, F. Medeiros, and A. Saleemuddin A candidate precursor to serous carcinoma that originates in the distal fallopian tube J Pathol 211 1 2007 Jan 26 35 (Pubitemid 46092026)
7. E. Kuhn, A. Meeker, T.L. Wang, A.S. Sehdev, R.J. Kurman, and M. Shih Ie Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis Am J Surg Pathol 34 6 Jun 2010 829 836
8. Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 455 7216 Oct 23 2008 1061 1068
9. E. Jarboe, A. Folkins, M.R. Nucci, D. Kindelberger, R. Drapkin, and A. Miron Serous carcinogenesis in the fallopian tube: a descriptive classification Int J Gynecol Pathol 27 1 Jan 2008 1 9 (Pubitemid 351627965)
10. B.M. Norquist, R.L. Garcia, K.H. Allison, C.H. Jokinen, L.E. Kernochan, and C.C. Pizzi The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations Cancer 116 22 Nov 15 2010 5261 5271
11. S.S. Andersen Spindle assembly and the art of regulating microtubule dynamics by MAPs and Stathmin/Op18 Trends Cell Biol 10 7 Jul 2000 261 267 (Pubitemid 30387030)
12. U. Marklund, N. Larsson, H.M. Gradin, G. Brattsand, and M. Gullberg Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics EMBO J 15 19 Oct 1 1996 5290 5298 (Pubitemid 26336212)
13. C. Iancu-Rubin, and G.F. Atweh p27(Kip1) and stathmin share the stage for the first time Trends Cell Biol 15 7 Jul 2005 346 348 (Pubitemid 40943522)
14. G. Baldassarre, B. Belletti, M.S. Nicoloso, M. Schiappacassi, A. Vecchione, and P. Spessotto p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion Cancer Cell 7 1 Jan 2005 51 63 (Pubitemid 40126382)
15. M. Mehrad, G. Ning, E.Y. Chen, K.K. Mehra, and C.P. Crum A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube Adv Anat Pathol 17 5 Sep 2010 293 302
16. A. Clauss, V. Ng, J. Liu, H. Piao, M. Russo, and N. Vena Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival Neoplasia 12 2 Feb 2010 161 172
17. J.F. Liu, M.S. Hirsch, H. Lee, and U.A. Matulonis Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma Gynecol Oncol 115 3 Dec 2009 401 406
18. A.M. Karst, K. Levanon, and R. Drapkin Modeling high-grade serous ovarian carcinogenesis from the fallopian tube Proc Natl Acad Sci USA 108 18 May 3 2011 7547 7552
19. S. Fotheringham, K. Levanon, and R. Drapkin Ex vivo culture of primary human fallopian tube epithelial cells JoVE 51 2011 10.3791/2728 http://www.jove.com/index/Details.stp?ID=2728
20. C.M. Counter, W.C. Hahn, W. Wei, S.D. Caddle, R.L. Beijersbergen, and P.M. Lansdorp Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization Proc Natl Acad Sci USA 95 25 Dec 8 1998 14723 14728 (Pubitemid 29003697)
21. W.C. Hahn, S.K. Dessain, M.W. Brooks, J.E. King, B. Elenbaas, and D.M. Sabatini Enumeration of the simian virus 40 early region elements necessary for human cell transformation Mol Cell Biol 22 7 Apr 2002 2111 2123 (Pubitemid 34224619)
22. K. Masutomi, E.Y. Yu, S. Khurts, I. Ben-Porath, J.L. Currier, and G.B. Metz Telomerase maintains telomere structure in normal human cells Cell 114 2 Jul 25 2003 241 253 (Pubitemid 36936917)
23. S.A. Stewart, D.M. Dykxhoorn, D. Palliser, H. Mizuno, E.Y. Yu, and D.S. An Lentivirus-delivered stable gene silencing by RNAi in primary cells RNA 9 4 Apr 2003 493 501 (Pubitemid 36356735)
24. W. Xian, A. Miron, M. Roh, D.R. Semmel, Y. Yassin, and J. Garber The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal fallopian tube J Pathol 220 1 Jan 2010 17 23
25. P.A. Shaw, M. Rouzbahman, E.S. Pizer, M. Pintilie, and H. Begley Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers Mod Pathol 22 9 Sep 2009 1133 1138
26. C.I. Rubin, and G.F. Atweh The role of stathmin in the regulation of the cell cycle J Cell Biochem 93 2 Oct 1 2004 242 250 (Pubitemid 44264202)
27. A.R. Laury, J.L. Hornick, R. Perets, J.F. Krane, J. Corson, and R. Drapkin PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma Am J Surg Pathol 34 5 May 2010 627 635
28. N.J. Bowen, S. Logani, E.B. Dickerson, L.B. Kapa, M. Akhtar, and B.B. Benigno Emerging roles for PAX8 in ovarian cancer and endosalpingeal development Gynecol Oncol 104 2 Feb 2007 331 337 (Pubitemid 46135661)
29. K. Levanon, V. Ng, H.Y. Piao, Y. Zhang, M.C. Chang, and M.H. Roh Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis Oncogene 29 8 Feb 25 2010 1103 1113
30. A.A. Ahmed, D. Etemadmoghadam, J. Temple, A.G. Lynch, M. Riad, and R. Sharma Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary J Pathol 221 1 May 2010 49 56
31. M. Murphy, J. Ahn, K.K. Walker, W.H. Hoffman, R.M. Evans, and A.J. Levine Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a Genes Dev 13 19 Oct 1 1999 2490 2501 (Pubitemid 29489641)
32. J. Ahn, M. Murphy, S. Kratowicz, A. Wang, A.J. Levine, and D.L. George Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction Oncogene 18 43 Oct 21 1999 5954 5958 (Pubitemid 29520452)
33. J.I. Johnsen, O.N. Aurelio, Z. Kwaja, G.E. Jorgensen, N.S. Pellegata, and R. Plattner p53-mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest Int J Cancer 88 5 Dec 1 2000 685 691
34. E. Alli, J.M. Yang, and W.N. Hait Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53 Oncogene 26 7 Feb 15 2007 1003 1012
35. I.M. Chu, L. Hengst, and J.M. Slingerland The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy Nat Rev Cancer 8 4 Apr 2008 253 267 (Pubitemid 351430863)
36. L.H. Saal, P. Johansson, K. Holm, S.K. Gruvberger-Saal, Q.B. She, and M. Maurer Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity Proc Natl Acad Sci USA 104 18 May 1 2007 7564 7569 (Pubitemid 47185946)
37. J.N. Andersen, S. Sathyanarayanan, A. Di Bacco, A. Chi, T. Zhang, and A.H. Chen Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors Sci Transl Med 2 43 Aug 4 2010 43ra55
38. R.C. Jordan, G. Bradley, and J. Slingerland Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity Am J Pathol 152 2 Feb 1998 585 590 (Pubitemid 28106405)
39. C. Cordon-Cardo, A. Koff, M. Drobnjak, P. Capodieci, I. Osman, and S.S. Millard Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma J Natl Cancer Inst 90 17 Sep 2 1998 1284 1291 (Pubitemid 28433473)
40. F. De Paola, A.M. Vecci, A.M. Granato, M. Liverani, F. Monti, and A.M. Innoceta p27/kip1 expression in normal epithelium, benign and neoplastic breast lesions J Pathol 196 1 Jan 2002 26 31
41. C.J. Sherr, and J.M. Roberts CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev 13 12 Jun 15 1999 1501 1512 (Pubitemid 29297917)
42. K.I. Nakayama, and K. Nakayama Ubiquitin ligases: cell-cycle control and cancer Nat Rev Cancer 6 5 May 2006 369 381